Stockreport

Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III [Yahoo! Finance]

Definium Therapeutics, Inc. - Common Shares  (DFTX) 
PDF Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III [Read more]